Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/135359
Advancing the repurposing of ivermectin for malaria
Journal Title
Authors
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
There is ever-increasing anticipation for the potential of mass drug administration of endectocides (also known as systemic insecticides) to reduce malaria transmission, with ivermectin emerging as the most likely first-in-class endectocide.1 More than half of the 46 papers published on this subject in the past decade appeared in the past 2 years. 23 projects are registered in the MESA Track database, of which seven are active today; and, more importantly, trial mapping by the Malaria Ivermectin Roadmap2 shows that abundant new evidence on the topic will be available by 2020.
Subject
Subject (English)
Citation
Collections
Citation
CHACCOUR, Carlos and RABINOVICH, Regina. Advancing the repurposing of ivermectin for malaria. The Lancet. 2019. Vol. 393, num. 10180, pags. 1480-1481. ISSN 0140-6736. [consulted: 7 of June of 2026]. Available at: https://hdl.handle.net/2445/135359